Gary Sender - 29 May 2024 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Reporting relationship: Director
Issuer ticker: HRMY
Reported as of: 29 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 May 2024, 08:58:04 UTC
Prior SEC filing: 16 Jun 2023
Next SEC filing: 20 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Christian Ulrich, Attorney-in-Fact

Key filing fact

Gary Sender filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 31 May 2024.

Key facts

This page summarizes Gary Sender's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 31 May 2024, 08:58.

Change

Previous filing in this sequence was filed on 16 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRMY transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +11,657
Change %
Price: $0.000000
Shares after: 11,657
Date: 29 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,657
Exercise price: $29.33
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1. The stock option shall vest in full on the earlier to occur of (i) May 29, 2025 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.